HomeCompareTCEHY vs JNJ

TCEHY vs JNJ: Dividend Comparison 2026

TCEHY yields 0.91% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TCEHY wins by $3.34M in total portfolio value
10 years
TCEHY
TCEHY
● Live price
0.91%
Share price
$62.84
Annual div
$0.57
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.37M
Annual income
$2,784,274.79
Full TCEHY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — TCEHY vs JNJ

📍 TCEHY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTCEHYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TCEHY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TCEHY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TCEHY
Annual income on $10K today (after 15% tax)
$77.45/yr
After 10yr DRIP, annual income (after tax)
$2,366,633.57/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, TCEHY beats the other by $2,362,647.58/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TCEHY + JNJ for your $10,000?

TCEHY: 50%JNJ: 50%
100% JNJ50/50100% TCEHY
Portfolio after 10yr
$1.70M
Annual income
$1,394,482.09/yr
Blended yield
81.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TCEHY
Analyst Ratings
3
Buy
Consensus: Buy
Price Target
$102.00
+62.3% upside vs current
Range: $102.00 — $102.00
Altman Z
4.5
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TCEHY buys
5
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTCEHYJNJ
Forward yield0.91%2.13%
Annual dividend / share$0.57$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$3.37M$30.3K
Annual income after 10y$2,784,274.79$4,689.40
Total dividends collected$3.30M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$102.00$228.73

Year-by-year: TCEHY vs JNJ ($10,000, DRIP)

YearTCEHY PortfolioTCEHY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,882$182.24$10,592$272.30+$290.00TCEHY
2$12,015$370.70$11,289$357.73+$726.00TCEHY
3$13,621$764.99$12,123$472.89+$1.5KTCEHY
4$16,195$1,621.03$13,141$629.86+$3.1KTCEHY
5$20,932$3,602.67$14,408$846.81+$6.5KTCEHY
6$31,100$8,703.32$16,021$1,151.60+$15.1KTCEHY
7$57,448$24,170.81$18,122$1,588.22+$39.3KTCEHY
8$144,924$83,454.59$20,930$2,228.20+$124.0KTCEHY
9$548,584$393,515.84$24,792$3,191.91+$523.8KTCEHY
10$3,371,260$2,784,274.79$30,274$4,689.40+$3.34MTCEHY

TCEHY vs JNJ: Complete Analysis 2026

TCEHYStock

Tencent Holdings Limited, an investment holding company, provides value-added services (VAS) and Online advertising services in Mainland China and internationally. The company operates through VAS, Online Advertising, FinTech and Business Services, and Others segments. It offers online games and social network services; FinTech and cloud services, and online advertising services. The company is also involved in the production, investment, and distribution of films and television programs for third parties, as well as copyrights licensing, merchandise sales, and other activities. n addition, it develops software; develops and operates online games; and provides information technology, information system integration, asset management, online literature, and online music entertainment services. Tencent Holdings Limited company was founded in 1998 and is headquartered in Shenzhen, the People's Republic of China.

Full TCEHY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this TCEHY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TCEHY vs SCHDTCEHY vs JEPITCEHY vs OTCEHY vs KOTCEHY vs MAINTCEHY vs ABBVTCEHY vs MRKTCEHY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.